Norovirus Narita 104 Virus-Like Particles Expressed inNicotiana benthamianaInduce Serum and Mucosal Immune Responses

Genotypic and Epidemiologic Trends of Norovirus Outbreaks in the United States, 2009 to 2013

(2013) E. Vega et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-Like Particle Vaccine

(2012) Erin M. Jackson et al.   PLoS One

A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

(2012) John T. Schiller et al.   VACCINE

Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations

(2011) Huafang Lai et al.   PLANT CELL REPORTS

Spurious polyadenylation of Norovirus Narita 104 capsid protein mRNA in transgenic plants

(2011) Lolita G. Mathew et al.   PLANT MOLECULAR BIOLOGY

Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine

(2011) Lissette S. Velasquez et al.   VACCINE

An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like Particles

(2010) L. S. Velasquez et al.   Clinical and Vaccine Immunology

Success stories in molecular farming-a brief overview

(2010) Loïc Faye et al.   PLANT BIOTECHNOLOGY JOURNAL

A DNA replicon system for rapid high-level production of virus-like particles in plants

(2009) Zhong Huang et al.   BIOTECHNOLOGY AND BIOENGINEERING

Norovirus Gastroenteritis

(2009) Roger I. Glass et al.   NEW ENGLAND JOURNAL OF MEDICINE

An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles

(2008) Luca Santi et al.   VACCINE